Table 5.

Comparison among the 3 pathways of patient demographic and clinical characteristics, length of episode, no. of visits, and health care impact variables for general abdominal pain: N=79 patients.

VARIABLEPATHWAY 1*
n=43 (54.4%)
PATHWAY 2*
n=7 (8.9%)
PATHWAY 3*
n=29 (36.7%)
Mean age, y62.0960.8658.03
Female sex, n (%)30 (69.8)5 (71.4)17 (58.6)
Prior psychological conditions, n (%)15 (34.9)5 (71.4)10 (34.5)
Prior chronic conditions, n (%)30 (69.8)7 (100.0)20 (69.0)
No. of visits, n (%)
    • 136 (83.7)0 (0.0)26 (89.7)
    • 26 (14.0)2 (28.6)2 (6.9)
    • ≥31 (2.3)5 (71.4)1 (3.4)
Mean length of episode, mo P<.0010.4916.860.38
Mean no. visits P<.0011.264.001.14
Common diagnosesNAIrritable bowel syndrome (50.0%)
Anxiety
Diverticular disease (26.5%)
Constipation
GI infection
Prescribed medications, n (%) P=.03119 (44.2)6 (85.7)20 (69.0)
Received investigations, n (%)8 (18.6)2 (28.6)9 (31.0)
Received laboratory tests, n (%)3 (7.0)0 (0.0)2 (6.9)
Received referrals, n (%) P=.0029 (20.9)6 (85.7)7 (24.1)
  • GI—gastrointestinal, NA—not applicable.

  • * Pathway 1—symptom remains with no diagnosis; pathway 2—diagnosis made and symptom persists; pathway 3—diagnosis made and no further visits for the symptom.

  • Tested using ANOVA (analysis of variance).

  • Tested using Embedded Image2 test.